Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,058 recalls, newest first

Class II · Moderate risk

Tinactin (Tolnaftate 1%)

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Terminated Chemical / undeclared Bayer Healthcare Pharmaceuticals Inc. NDC 11523-0777-2 D-0245-2022
Class II · Moderate risk

Tinactin (Tolnaftate 1%)

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Terminated Chemical / undeclared Bayer Healthcare Pharmaceuticals Inc. NDC 11523-0072-5 D-0244-2022
Class II · Moderate risk

Tinactin (Tolnaftate 1%)

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Terminated Chemical / undeclared Bayer Healthcare Pharmaceuticals Inc. NDC 11523-0165-3 D-0243-2022
Class II · Moderate risk

Tinactin (Tolnaftate 1%)

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Terminated Chemical / undeclared Bayer Healthcare Pharmaceuticals Inc. NDC 11523-4162-1 D-0242-2022
Class II · Moderate risk

Lotrimin AF

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Terminated Chemical / undeclared Bayer Healthcare Pharmaceuticals Inc. NDC 11523-4327-1 D-0241-2022
Class II · Moderate risk

Lotrimin Af

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Terminated Chemical / undeclared Bayer Healthcare Pharmaceuticals Inc. NDC 11523-0010-2 D-0240-2022
Class II · Moderate risk

Lotrimin Af

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Terminated Chemical / undeclared Bayer Healthcare Pharmaceuticals Inc. NDC 11523-0010-1 D-0239-2022
Class II · Moderate risk

Lotrimin Af

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Terminated Chemical / undeclared Bayer Healthcare Pharmaceuticals Inc. NDC 11523-0544-2 D-0238-2022
Class II · Moderate risk

Lotrimin Af

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Terminated Chemical / undeclared Bayer Healthcare Pharmaceuticals Inc. NDC 11523-4140-2 D-0237-2022
Class II · Moderate risk

Lotrimin Af

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Terminated Chemical / undeclared Bayer Healthcare Pharmaceuticals Inc. NDC 11523-1272-2 D-0236-2022
Class II · Moderate risk

Artesunate for Injection

Lack of Assurance of Sterility: Air filter failed post integrity test leading to a lack of sterility assurance.

Terminated Sterility / contamination Amivas (US), LLC NDC 73607-001-02 D-0002-2022
Class II · Moderate risk

Hydroquinone USP

Finished product specification did not meet USP specifications.

Terminated Other Monarch PCM, LLC NDC 69367-174-01 D-0855-2021

Recalls by year